Showing results (31-40 of 162) with videos related to

Sort By:
Pageof 17
Clinical Journal of Gastroenterology|November 23, 2021
A case of conversion hepatectomy for huge ruptured hepatocellular carcinoma after transarterial embolization and lenvatinib therapyAtsushi Naganuma, Yuhei Suzuki, Takashi Hoshino, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|January 8, 2026
Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort StudySatoshi Takakusagi, Satoru Kakizaki, Yozo Yokoyama, et al.
Cancers|February 25, 2023
Relationship between Being Overweight and Clinical Outcomes of Ablation Therapy for Hepatocellular Carcinoma under Ultrasound Guidance: A Retrospective AnalysisTakeshi Hatanaka, Yutaka Yata, Naoto Saito, et al.
Biological Trace Element Research|April 29, 2021
Efficacy of Zinc Acetate Treatment for Patients with Decompensated Liver Cirrhosis Complicated by HypozincemiaSuguru Horiguchi, Atsushi Naganuma, Yumeo Tateyama, et al.
Oncology|September 13, 2021
Lenvatinib for Hepatocellular Carcinoma Patients with Nonviral Infection Who Were Unlikely to Respond to Immunotherapy: A Retrospective, Comparative StudyTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective StudyTakeshi Hatanaka, Satoru Kakizaki, Daisuke Uehara, et al.
Case Reports in Gastroenterology|March 30, 2022
Successful Treatment of Pancreatic Fistula Following Surgery for Congenital Biliary Dilatation with Endoscopic Ultrasound-Guided Transduodenal DrainageShigemasa Suzuki, Norio Kubo, Nobuhiro Hosoi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 25, 2019
Analyses of objective response rate, progression-free survival, and adverse events in hepatocellular carcinoma patients treated with lenvatinib: A multicenter retrospective studyTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Cancers|October 14, 2020
Liver Function Changes in Patients with Hepatocellular Carcinoma Treated with Lenvatinib: Predictive Factors of Progression to Child-Pugh Class B, the Formation of Ascites and the Candidates for the Post-Progression TreatmentTakeshi Hatanaka, Satoru Kakizaki, Tamon Nagashima, et al.
Alimentary Pharmacology & Therapeutics|June 16, 2022
Improved survival of viral hepatocellular carcinoma but not non-viral hepatocellular carcinoma from 2000 to 2020: A multi-centre cohort study of 6007 patients from high-volume academic centres in JapanHidenori Toyoda, Kazuya Kariyama, Atsushi Hiraoka, et al.
Pageof 17